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Abstract
Motivated by genetic association studies of pleiotropy, we propose here a
Bayesian latent variable approach to jointly study multiple outcomes or pheno-
types. The proposed method models both continuous and binary phenotypes,
and it accounts for serial and familial correlations when longitudinal and pedi-
gree data have been collected. We present a Bayesian estimation method for
the model parameters, and we develop a novel MCMC algorithm that builds
upon hierarchical centering and parameter expansion techniques to efficiently
sample the posterior distribution. We discuss phenotype and model selection in
the Bayesian setting, and we study the performance of two selection strategies
based on Bayes factors and spike-and-slab priors. We evaluate the proposed
method via extensive simulations and demonstrate its utility with an applica-
tion to a genome-wide association study of various complication phenotypes
related to type 1 diabetes.
Keywords: Bayesian inference, Genetics, Latent variable, Markov chain Monte
Carlo, Path Sampling, Pleiotropy
1 Introduction
Pleiotropy occurs when a single genetic factor influences multiple continuous or binary
phenotypes, and it is present in many genetic studies of complex human traits such as
diabetes, hypertension and cardiovascular diseases. In genetic studies of complications
or secondary manifestations of a disease, it is often believed that there are common
genetic risk factors for the different phenotypes. In other cases, the primary and
often conceptual phenotype (e.g. disease severity) may not be directly measured or be
characterized by one single phenotype, and a set of surrogate response variables must
instead be used. These response variables (phenotypes or outcomes) are mutually
correlated as they measure the underlying trait from different perspectives. In order
to take into account all information and to increase statistical efficiency, it is desirable
to model these outcomes jointly.
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An added characteristic of many emerging large-scale genetic studies is the col-
lection of repeated measures over time in correlated individuals (family data). For
example, the ongoing T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-
generation sequencing in multi-Ethnic Samples) consortium study includes longitudi-
nal measures of various T2D-revelant phenotypes (e.g. blood glucose levels and blood
pressures) and other covariates (e.g. sex, body mass index and medication history),
and these measures are collected for 2,500 individuals from 85 Mexican-American
families. Similarly, the DCCT (Diabetes Control and Complications Trial) study in-
cludes longitudinal measures of various type 1 diabetes (T1D) complications, which
we analyze in this paper.
The longitudinal family studies combine the features of longitudinal studies in
independent individuals and studies using single-time-point phenotype measures in
families, providing more information about the genetic and environmental factors as-
sociated with the traits of interest than cross-sectional studies (Burton et al., 2005).
However, joint modeling of multiple phenotypes using longitudinal family data in-
volves non-trivial statistical and computational challenges because of the complex
correlations that exist between different phenotypes (the phenotypical correlation),
between repeated measures from the same phenotype (the serial correlation) and
between individuals within the same family (the familial correlation).
Robust and powerful methods for the study of pleiotropy are under-developed in
the literature due to data complexities that include a) the phenotypes of interest can
be continuous, discrete or both, b) the joint effect of covariates on the multiple pheno-
types is difficult to specify, and c) the familial, serial and other correlations are often
present in the data as discussed above. There are a number of approaches proposed
for cross-sectional data. For instance, Xu et al. (2003) extended the standard linear
combination test to incorporate data-driven weighting factors, Weller et al. (1996)
applied the principal component analysis to the multiple traits of interest to obtain
independent canonical variables and then conducted univariate quantitative trait lo-
cus (QTL) analyses, and Lange and Whittaker (2001) developed a QTL-mapping
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method based on generalized estimating equations.
Here we propose to use the latent variable (LV) methodology to jointly study
multiple correlated phenotypes in the presence of serial and familial correlations.
The formulation of a latent variable model (LVM) relies on postulating the effect of
a random variable that is not observed by the researchers but is assumed to exert
an important influence on the set of observed variables (also known as the manifest
variables) and thus induces correlations among them (Bartholomew et al., 2011). In
the context of pleiotropy studies, the manifest variables are the multiple observed
phenotypes, which jointly inform the latent variable that represents the underlying
conceptual disease status or severity.
The LV methodology has been widely used in many scientific fields including
economics, psychology and social sciences, and it is becoming increasingly attractive
for genetic studies. For example, O’Hara et al. (2010) proposed a LV approach for
the analysis of multivariate quantitative trait loci, Tayo et al. (2008) applied a factor
analysis (a sub-type of LVM) to find latent common genetic components of obesity
traits, and Nock et al. (2009) used the factor analysis for a metabolic syndrome study.
Initial applications of LVM focused on reducing the number of manifest variables to a
smaller number of latent outcomes. Sammel and Ryan (1996) and Sammel and Ryan
(1997) extended the LVM to allow covariates to have effects on both the manifest and
latent variables. Roy and Lin (2000) discussed a LV approach for longitudinal data
with continuous outcomes.
The proposed LVM consists of two parts. The first part models the relationship
between the manifest variables and the LV to characterize the within-subject cor-
relation among the different outcomes. The second part uses a linear mixed effect
model to investigate the effect of a genetic marker and other covariates on the LV,
accounting for the serial and familial correlations. Direct effects of covariates on the
manifest variables are also allowed in the first part of model.
The paper makes a number of original contributions. The proposed LV method
generalizes the work of Roy and Lin (2000) to longitudinal family data with binary
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and continuous responses. The Bayesian formulation can be desirable in practice
as it offers a principled way to incorporate prior information, often available in ge-
netic studies, and to perform finite sample likelihood-based inference. However, the
Bayesian model raises important computational challenges because the sampling al-
gorithm required to study the posterior is inefficient when it is applied in its standard
form. We introduce a novel algorithm that relies on the hierarchical centering and
parameter expansion techniques (Gelfand, 1995; Liu and Wu, 1999; Meng and van
Dyk, 1999) to improve computational efficiency.
The rest of the paper is organized as follows. Section 2 introduces the details
of the LVM and discusses the consequences of na¨ıvely ignoring the family structure
in the data. Section 3 presents a Bayesian estimation for the model parameters and
a novel MCMC algorithm designed to sample the posterior distribution efficiently.
Section 4 discusses phenotype selection and model selection in the Bayesian setting.
Section 5 shows results from extensive simulation studies, and Section 6 applies the
proposed method to a genetic study of T1D complications. Section 7 concludes with
recommendations and further discussions.
2 Latent Variable Model for Longitudinal Family
data.
2.1 The Statistical Model
Let Ycit = (ycit1, . . . , ycitJ)
′
be the J × 1 vector of outcomes/phenotypes/manifest
variables measured at the tth time on the ith individual from the cth family/cluster for
c = 1, 2, . . . , C, i = 1, 2, . . . , Nc, t = 1, 2, . . . , T , where C denotes the total number of
families, Nc is the number of individuals within the c
th family, and T is the total num-
ber of repeated measurements. Among the J outcomes, Yccit = (y
c
cit1, . . . , y
c
citJ1
)
′
are
continuous and Ybcit = (y
b
citJ1+1
, . . . , ybcitJ)
′
are binary. Let Ucit be the LV representing
the conceptual disease severity which aggregates the partial information brought by
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each of the J phenotypes.
In the first part of the LVM, a continuous phenotype yc is linked to the latent
trait U via a linear mixed model
yccitj = β0j +W
T
citβj + λjUcit + bcij + ecitj, (2.1)
where ecitj
iid∼ N(0, σ2j ), Wcit is a p1-dimensional vector of covariates that have direct
effects on the phenotype (direct fixed-effect covariates) and λj is the factor loading
that represents the effect of the LV on the jth phenotype. When all λjs are equal to 1,
model (2.1) is reduced to a mixed effect model. The random component bcij captures
the family-specific within-subject correlations over time. We assume bcij
iid∼ N(0, τ 2j ),
and ecitj and bcij are mutually independent for c = 1, . . . , C, i = 1, . . . , Nc, t = 1, . . . , T
and j = 1, . . . , J .
If a phenotype is binary, a generalized linear mixed model is assumed,
ηcitj = β0j +W
T
citβj + λjUcit + bcij, (2.2)
with a probit link,
E
[
ybcitj|Ucit, bcij
]
= p(ybcitj = 1|Ucit, bcij) = Φ(ηcitj). (2.3)
We choose a probit link instead of a logit link to gain computational efficiency. Specif-
ically, we take advantage of the well-known representation of the probit model based
on a normally distributed LV. If y˜bcitj ∼ N(ηcitj, 1) is the Gaussian variable underlying
the binary response ybcitj, then (2.3) is recovered when y
b
citj = 1{y˜bcitj>0}.
The second part of the LVM assess the effect of Xcit, a p2−dimensional vector
of variables that of primary interest (e.g. a genetic marker and possibly additional
clinical factors), on the latent variable U via a linear mixed model,
Ucit = X
T
citα + Z
T
citac +Q
T
citdci + cit, (2.4)
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where cit
iid∼ N(0, ψ2). Elements in X are also called indirect fixed-effect covariates
because their effects on a phenotype of interest Y is induced via the effect of the latent
variable U on Y modelled in first part of the LVM above. Pleiotropy is detected if
the element of α corresponding to the genetic marker is found to be significant. We
assume ac ∈ Rq1×1 are the family-specific random effects and Zcit is the corresponding
vector of covariates. Similarly, dci ∈ Rq2×1 represents the subject-specific random
effects with Qcit its associated covariate vector. We assume that ac
iid∼MVNq1(0,ΣA),
dci
iid∼MVNq2(0,ΣD) and all random effects are independent of the cit.
2.2 Model Identification Restrictions
The following modification of equation (2.1)
yccitj = β0j +W
T
citβj + λjK
−1KUcit + bcij + ecitj, (2.5)
whereK is an arbitrary nonzero number, suggests that, without any restriction on λ or
the variance of Ucit, an infinite number of equivalent models can be created. A similar
phenomenon appears in the binary phenotype case. In order to avoid unidentifiability,
we assume that the variance of Ucit is equal to 1 and that λj is non-negative. Because
we allow covariate effects in both parts of the LVM, we assume that the two sets of
covariates are disjoint and equation (2.4) does not contain the intercept.
2.3 Effects of Ignoring Familial Correlation
Individuals from the same family are genetically related resulting in correlation be-
tween their latent disease status. In practice, to reduce the analytic complexity and
computation burden, one may choose to assume sample independence and apply ex-
isting methods (e.g. Roy and Lin (2000)). However, ignoring the family structure will
cause incorrect inference for the model parameters. To see this clearly, we assume a
simplified case where the phenotypes of interest are all continuous and there are no
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repeated measures. The two parts of LVM are reduced to
ycij = β0j +W
T
ciβj + λjUci + ecij, and Uci = X
T
ciα + Z
T
ciac + ci,
where c = 1, . . . , C, i = 1, . . . , Nc and j = 1, . . . , J , with independent error terms
ecij ∼ N(0, σ2j ) and ci ∼ N(0, 1), λj > 0 and ac ∼ N(0,ΣA).
The variance of the jth response for individual i from family c can be decomposed
in terms of the model parameters as:
V ar(ycij) = σ
2
j + λ
2
jZ
T
ciΣAZci + λ
2
j . (2.6)
Suppose we ignore the familial correlation in the data and propose the following model
yhj = β0j +W
T
h βj + λ˜jU˜h + ehj, and U˜h = X
T
h α˜ + h,
where h = 1, . . . , N is the individual’s index and N is the total sample size. In this
case, the variance of the jth response for individual h is decomposed as
V ar(yhj) = σ
2
j + λ˜
2
j . (2.7)
By equating (2.6) and (2.7), we find that λ˜2j = (Z
T
ciΣAZci + 1)λ
2
j and thus it is easy
to see that
α˜ =
λj
λ˜j
α =
1√
(ZTciΣAZci + 1)
α < α.
Therefore, ignoring familial correlation can lead to significant underestimation of α,
the effect of a genetic marker on the LV of interest. However, the omission of existing
familial correlation leads to overestimation of λ, the effect of the LV on the phenotypes
of interest in the first part of the LVM, as demonstrated in the simulation studies of
Section 5.2 below. This is consistent with what’s reported in the statistical genetics
literature (e.g. Thornton and McPeek (2010)).
In the longitudinal setting, as seen from equation (2.4), ignoring the familial cor-
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relation will also result in biased estimation of λ and α, as well as the serial correlation
ΣD. Simulation results reported in Section 5 support these conclusions. However, par-
ticular to the longitudinal setting, if covariates Z are not present, the error caused
by ignoring the familial correlation can be absorbed into the serial correlation and
thus only ΣD will be incorrectly estimated. Nevertheless, there is still some loss of
efficiency in the estimation of λ and α in this case.
3 Parameter Estimation via Bayesian Method
Traditional solutions for LVM, including the popular software such as LISREL (Jo¨reskog
and So¨rbom, 1996) and MPLUS (Muthen and Asparouhov, 2011), rely on frequen-
tist methods. The development of modern computational algorithms, in particular
Markov chain Monte Carlo (MCMC), enables us to use LVM for dependent data
within the Bayesian paradigm. The Bayesian approach also offers a principled ap-
proach to produce finite sample likelihood-based inference and to incorporate any
available prior information which, in a genetic analysis setup, can be considerable.
3.1 Bayesian Model Setup
The data in our model contain the observed continuous or binary outcomes Y,
the direct fixed-effect covariates W , the indirect fixed-effect covariates X, and the
random-effect covariates Z and Q. The vector of parameters of interest is Θ =
(β0,β, α, λ, τ
2, σ2,ΣA,ΣD)
′
where β0 = (β01, . . . , β0J)
′
, β = (β
′
1, . . . , β
′
J)
′
where βj =
(βj1, . . . , βjp1)
′
, α = (α1, . . . , αp2)
′
, λ = (λ1, . . . , λJ)
′
, τ 2 = (τ 21 , . . . , τ
2
J )
′
and σ2 =
(σ21, . . . , σ
2
J1
)
′
. Therefore, the posterior distribution for the model parameters is
p(Θ|Y,W,X,Z,Q) ∝ p(Θ)p(Y|Θ,W,X,Z,Q).
The complexity of the sampling model requires the use of MCMC algorithms for
statistical inference. Unfortunately, the commonly used priors in probit and linear
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mixed effects models along with a run-of-the-mill sampling scheme lead to a torpidly
mixing chain. In the next section, we discuss the prior specifications and the algo-
rithmic modifications that we have implemented to improve the MCMC efficiency.
3.2 MCMC sampling
We follow the data augmentation (DA) principle of Tanner and Wong (1987) and
sample alternatively from the posterior distribution given the complete data and
from the LV’s distribution given the observed data and the parameter values. We first
discuss the sampling scheme for the relatively simple case when all the phenotypes
are continuous and we then extend the algorithm to binary phenotypes.
3.2.1 Continuous Traits
When all the phenotypes are continuous and the conditional conjugate priors are
defined for the model parameters, a standard Gibbs (SG) sampler can be used for
MCMC sampling from the posterior distribution. However, due to high dependence
between the components of the Markov chain corresponding to the parameter vector
Θ and the missing and latent data vector Ω, we observe a very slow mixing of the
chain. Improvement can be obtained by using hierarchical centering (HC) (Gelfand,
1995). The HC technique moves the parameters up the hierarchy via model reformu-
lation. Specifically, in (2.1) we move β0j’s up the model hierarchy to be the mean of
the random effect b so that the new random effect is b∗cij = β0j + bcij.
Another technique devised to overcome the slow convergence problem of DA
algorithms is parameter expansion (PX) (Meng and van Dyk, 1999; Liu and Wu,
1999). The idea behind PX is to introduce auxiliary parameters in the model and
average over all their possible values in order to produce inference for the original
model of interest. As demonstrated by Meng and van Dyk (1999) and Liu and Wu
(1999), the benefits of this apparently circuitous strategy can be highly significant,
because the larger parameter space allows the Markov chain to move more freely and
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breaks the dependence between its components.
In our implementations, we have observed a strong coupling between the updates
of the random effect bcij and its variance τ
2
j , and between the factor loading λj and
the latent factor U for all 1 ≤ j ≤ J . For instance, an update of τ 2j close to zero likely
yields a small update of bcij and vice versa. Thus, we introduce auxiliary parameters
ξj and ψ and define the following PX with hierarchical centering model (PX-HC)
yccitj = W
T
citβj + λ
∗
jU
∗
cit + ξjb
∗
cij + ecitj, with (3.1)
U∗cit = X
T
citα
∗ + ZTcita
∗
c +Q
T
citd
∗
ci + 
∗
cit, (3.2)
where b∗cij ∼ N(β∗0j, η2j ), a∗c iid∼ MVNq1(0,Σ∗a), d∗ci iid∼ MVNq2(0,Σ∗d), and ∗cit iid∼
N(0, ψ2). To relate the original parameters to the expanded parameters, the fol-
lowing transformations are used
α = α∗/ψ, Ucit = U∗cit/ψ, ΣA = Σ
∗
A/ψ
2, ΣD = Σ
∗
D/ψ
2,
λj = λ
∗
jψ, βj0 = β
∗
j0ξj, τ
2
j = ξ
2
j η
2
j , for all 1 ≤ j ≤ J.
The conjugate priors used for the auxiliary parameters involved in the PX scheme
lead to a Gibbs sampler in which each conditional distribution is available in closed
form and induce the folded-t (the absolute value of t distribution) prior distributions
for the parameters τ and λ. More precisely, since Var(b∗cij) = η
2
j in our PX-HC model
and Var(bcij) = τ
2
j in the original model, we have τj = |ξj|ηj. When the conditional
conjugate normal and inverse-Gamma prior are applied to ξj and η
2
j , respectively, the
resulting prior for τj is the folded-t distribution. Similarly, since λj = λ
∗
jψ, a half
normal prior assigned to λ∗j and inverse-Gamma prior to ψ
2 will result in a folded-t
prior for λj. Other authors have discussed the suitability of folded-t priors in mixed
effects and factor analysis models. For instance, Gelman (2006) noted the added
flexibility and improved behaviour when random effects are small, and Ghosh and
Dunson (2009) suggested the use of t or folded-t priors for the factor loadings in a
11
factor analysis setting.
We consider independent and conjugate priors for the expanded model param-
eters Θ∗ = (β∗0 ,β, α
∗, λ∗, η2, σ2,Σ∗a,Σ
∗
d, ψ, ξ)
′
. For example, we use normal priors for
the fixed-effect coefficients. Thus,
β∗0j ∼ N(0, 1000), βj iid∼ Np1(0, 1000 ∗ Ip1), η2j ∼ Inv-Gamma
(
v2
2
, v2
2
)
, for 1 ≤ j ≤ J ;
α ∼ Np2(0, 1000 ∗ Ip2).
For the scale parameters, we specify conditional conjugate priors,
σ2j ∼ Inv-Gamma(0.1, 0.1) for j = 1, . . . , J ;
Σ∗a ∼ Inv-Wishart(Va, S−1a ) with Va = q1 + 1 and Sa = 10 ∗ Iq1;
Σ∗d ∼ Inv-Wishart(Vd, S−1d ) with Vd = q2 + 1 and Sd = 10 ∗ Iq2.
For the auxiliary parameters we have introduced, the priors are
ψ2 ∼ Inv-Gamma (v1
2
, v1
2
)
, ξj ∼ N(0, 1),
where v1 and v2 are the hyperparameters representing the degrees of freedom (df) of
the induced folded-t priors for λj and τ
2
j , respectively.
For the purpose of phenotype selection, which will be discussed in detail in Sec-
tion 4.1, we specify a spike-and-slab prior for λ∗j
p(λ∗j) = (1− pij)δ{0} + pijTN+(0, 1), (3.3)
with the hyperparameter pij ∼ Beta(a, b). Notice that the induced prior for λ in the
original inference model is also a spike-and-slab prior with the spike at zero and the
slab distribution equal to a folded-t distribution with v1 df.
After defining the conditional conjugate priors for the expanded model, we now
can apply the Gibbs sampling to obtain the posterior samples. Details of sampling
are described in the Appendix, and the key steps at a given iteration k − 1 are:
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Step 1: Draw Θ∗(k) from f(Θ∗|Ω∗(k−1),yc), which involves sampling (β ′1, ..., β ′J)′ , β∗0 ,
α∗, λ∗, η2, σ2, Σ∗a, Σ
∗
d, ψ, ξ, and
Step 2: Draw Ω∗(k) from f(Ω∗|Θ∗(k),yc), which involves sampling Ω∗ = (U∗, b∗, a∗, d∗)′ .
3.2.2 General Traits
Suppose that the phenotypes of interest includes both continuous and binary traits.
Without loss of generality, we assume that the first J1 phenotypes are continuous and
the remaining ones are binary. In order to address concerns involving the MCMC
mixing similar to those in the continuous response case, we define the model
yccitj = W
T
citβj + λ
∗
jU
∗
cit + ξjb
∗
cij + ecitj, 1 ≤ j ≤ J1, (3.4)
p(ybcitj = 1) = Φ(W
T
citβj + λ
∗
jU
∗
cit + ξjb
∗
cij), J1 + 1 ≤ j ≤ J, (3.5)
U∗cit = X
T
citα
∗ + ZTcita
∗
c +Q
T
citd
∗
ci + 
∗
cit, (3.6)
where b∗cij ∼ N(β∗0j, η2j ), a∗c iid∼ MVNq1(0,Σ∗a), d∗ci iid∼ MVNq2(0,Σ∗d), ∗cit iid∼ N(0, ψ2),
and the prior distributions are the same as in the continuous case.
A specific issue encountered here is that some of the conditional distributions
required in the Gibbs sampler are not available in closed form. One possible solution
is to employ the DA scheme proposed by Albert and Chib (1993) that uses the
underlying continuous variable y˜bcitj (discussed in Section 2.1) as an auxiliary variable,
so that all the conditional posterior densities in the expanded model can be directly
sampled from. However, even in the model defined by (3.4)−(3.6) we have noticed
strong posterior dependence between y˜bcitj and some of the model parameters which
triggered a sluggish mixing of the chain. We apply an additional layer of the PX
scheme by introducing a working parameter γj and a one-to-one mapping y˜
b∗
citj =
γj y˜
b
citj. We use the marginal DA scheme 3 of van Dyk and Meng (2001), leaving the
prior distributions and the parameterization of the model unchanged. We call this
algorithm the doubly parameter-expanded with hierarchical centering and denote it as
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PX2−HC. Below we summarize the kth iteration in the Gibbs sampling algorithm,
and we provide a complete description in the Appendix.
Step 1: Draw
y˜
b(k)
citj ∼
{
TN+(µ
∗
citj, 1), if y
b
citj = 1
TN−(µ∗citj, 1), if y
b
citj = 0
,
where µ∗citj = W
T
citβ
(k−1)
j + λ
∗(k−1)
j U
∗(k−1)
cit + ξ
(k−1)
j b
∗(k−1)
cij . Transform y˜
b
citj to y˜
b∗
citj
via y˜b∗citj = γj y˜
b
citj.
Step 2: For j = J1 + 1, ..., J , the order of updating (β
(k)
j , λ
∗(k)
j , ξ
(k)
j , γ
2(k)
j ) involves
sampling first γ
2(k)
j and then (β˜
(k)
j , λ˜
∗(k)
j , ξ˜
(k)
j ) from their respective conditional
densities. Set β
(k)
j = β˜
(k)
j /γ
(k)
j , λ
∗(k)
j = λ˜
∗(k)
j /γ
(k)
j , and ξ
(k)
j = ξ˜
(k)
j /γ
(k)
j .
The updates of the remaining parameters for the continuous responses and
for the second part of the LVM are the same as those for the case with only
continuous responses (see Section 3.2.1 and the Appendix).
Step 3: Draw Ω∗(k) from f(Ω∗|Θ∗(k), yc, y˜b∗(k)citj ).
Figures 1 and 2 illustrates the significant improvement, in terms of reduced autocor-
relation, brought by the additional layer of parameter expansion. See Section 5 for
details of the simulations and the Appendix for additional comparison plots.
4 Model and Variable Selection
4.1 Selection of Relevant Phenotypes
In medical research, it is of interest to determine if a phenotype under the study is
truly relevant to the latent disease status. In the LVM setting, this is equivalent to
testing if the coefficient or factor loading λj for the j
th phenotype ((2.1) for continuous
phenotype and (2.2) for binary phenotype) is statistically significant or not.
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The sign restriction on the factor loadings, λjs ≥ 0 as discussed in Section 2.2,
implies that the highest posterior density interval (HpdI) will seldom include zero
and is thus anti-conservative as a selection criterion. To assess the significance of the
factor loadings, we apply the Bayesian model selection method using the spike-and-
slab priors (Mitchell and Beauchamp, 1988; George and McCulloch, 1993; Chipman,
1996; Xu et al., 2011). Specifically, we use the spike-and-slab prior (3.3) for each λ∗j .
The point mass at zero shrinks small values of the factor loading towards zero, while
the values of a and b reflect the prior belief in λj = 0 (see Xu et al., 2011, for a
similar discussion on the use of spike-and-slab priors to alleviate the winner’s curse
in genetic association studies). When there is no prior information, we recommend
a = 1 and b = 1 which correspond to pij ∼ Unif(0, 1). For those phenotypes that are
a priori considered to be unrelated to the latent disease variable, we can set a = 0.25
and b = 1, thus favouring a priori small values for the corresponding λjs.
The determination of the relevance of the jth phenotype is based on the posterior
probability of positive loading, Pr(λj > 0|Y ). The sampling algorithm discussed in
the Appendix introduces the latent mixture indicator ωj = 1{λj>0}, so that Pr(λj >
0|Y ) can be approximated by the MCMC sample frequency of {ωj = 1}. Given a
pre-specified threshold φ, we assume that any loading with Pr(λj > 0|Y ) ≥ φ should
be included in the model. The value for φ depends on the practical problem. If the
number of manifest variables is large, the φ value can be chosen to control the overall
average Bayesian false discovery rate (FDR) (Morris et al., 2008). The performance
of selecting the correct phenotypes is shown in the simulation Section 5.3.1 below.
4.2 Model Selection Using Bayes Factor
Bayes factors are central to the Bayesian model selection and comparison. The Bayes
factor for comparing model M0 and M1 is defined as: BF =
P (Y |M1)
P (Y |M0) . Assuming equal
model priors for M0 and M1, the posterior odds of the two models equals to the Bayes
factor. A calibration of the Bayes factor is given by Kass and Raftery (1995) where
logBF > 1 supports M1 and logBF < 0 supports M0.
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The calculation of P (Y |Mk) in our setting is challenging as it involves high
dimensional integration. We follow the procedure of Lee and Song (2002) and use the
parametric arithmetic mean path (PAMP) implementation of the path sampling (see
also Dutta and Ghosh, 2012) to compute the Bayes factor. Specifically, we assume
an unnormalized density function fθ such that fθ0 and fθ1 are the sampling densities
for models M0 and M1, respectively. The two models are connected in the parametric
space Θ via a path P = {θg = gθ0 + (1 − g)θ1 : g ∈ [0, 1]}, where each θg ∈ P
corresponds to a model Mg for which the sampling density function is f(θg). The
Bayes factor can then be calculated using the identity
logBF = log
P (Y |M1)
P (Y |M0) =
∫ 1
0
EΩ,Θ[U(Y,Ω,Θ, g)]dg, (4.1)
where EΩ,Θ denotes the expectation with respect to the density p(Ω,Θ|Y, g), and
U(Y,Ω,Θ, g) = ∂
∂g
log p(Y,Ω|Θ, g). The dependence of p(Y,Ω|Θ, g) on g is due to
p(Y,Ω|Θ, g) ∝ p(Ω|Y,Θ)fθg(Y |Θ).
To compute the integral in equation (4.1), we choose S fixed values {g1, . . . , gS}
such that g(0) = 0 < g(1) < g(2) < ... < g(S) < 1 = g(S+1) and then estimate logBF by
̂logBF =
1
2
S∑
s=0
(g(s+1) − g(s))(U(s+1) + U(s)), (4.2)
where U(s) is the average of the values U(Y,Ω,Θ, g(s)) over all the MCMC samples
from p(Ω,Θ|Y, g(s)). That is,
U(s) =
1
M
M∑
k=1
U(Y,Ω(k),Θ(k), g(s)), (4.3)
in which {Ω(k),Θ(k); k = 1, ...,M} are the samples draws from p(Ω,Θ|Y, g(s)). To
estimate logBF , we run the PX−HC (or PH2−HC) sampling algorithm for each
of the grid points, calculate the values of the parameters and, finally, compute U.
This method is also called Path Sampling with Parameter Expansion (PS−PX) by
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Ghosh and Dunson (2009). In the context of pleiotropy studies, Bayes factors can
be applied to different hypotheses. In the remaining part of this section we illustrate
two instances of substantial interest.
4.2.1 Selection of Relevant Phenotypes via Bayes Factors.
We are concerned here with assessing the factor loadings, λjs, as discussed in Section
4.1. Suppose that we are interested in testing λj0 = 0. Let Mg be the model with fac-
tor loadings equal to (λ1, . . . , λj0−1, gλj0 , λj0+1, . . . , λJ)
′, where g ∈ [0, 1]. Thus, model
M0 has (λ1, . . . , λj0−1, 0, λj0+1, . . . , λJ)
′, and M1 has (λ1, . . . , λj0−1, λj0 , λj0+1, . . . , λJ)
′.
The first part of the LVM for Mg that links the phenotype Yjs and the LV U is
Vcitj = β0j +W
T
citβj + λjUcit + bcij + ecitj, if j 6= j0
Vcitj0 = β0j0 +W
T
citβj0 + gλj0Ucit + bcij0 + ecitj0 ,
(4.4)
where Vcitj = Ycitj for continuous phenotypes and Vcitj = Y˜
b
citj for binary phenotypes.
The second part of the LVM remains unchanged. We then have
U(Y,Ω,Θ, g(s)) =
1
σ2j0
C∑
c=1
Nc∑
i=1
T∑
t=1
[
Vcitj0 − (β0j0 +W Tcitβj0 + g(s)λj0Ucit + bcij0)
]
λj0Ucit,
where σ2j0 = 1 for the binary phenotypes. The logBF can then be obtained via
Equations (4.2) and (4.3) with U calculated using the above equation.
Dutta and Ghosh (2012) showed that the calculation of Bayes factor is valid when
limg→0EΩ,Θ[U(Y,Ω,Θ, g)] is finite. The condition holds when the prior distribution
for λ has the first two moments finite, which is true for our relatively diffuse folded-t
prior with ten df. To explore the sensitivity of the Bayes factor estimation to the
changes of df in the folded-t prior, we also consider df ∈ {3, 10, 40, 90}.
Another concern is the tuning of the grid sizes when using equation (4.2) as the
approximation of logBF . Dutta and Ghosh (2012) suggested a grid size no bigger
than 0.01, corresponding to 100 grid numbers in [0, 1]. However, due to conflict
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between the prior and sampling distributions, when λ is large, EΩ,Θ[U(Y,Ω,Θ, g)]
has large spikes when g is close to zero, but it stabilizes gradually as g increases.
Thus we suggest to use uneven grid size scheme so that smaller grid sizes are chosen
for g near zero. For example, in our simulations below we set the grid number to be
15 for g ∈ [0, 0.1] and also 15 for g ∈ [0.9, 1] and observed good results.
4.2.2 Selection of Pleiotropic Genetic Marker via Bayes Factors
An important inferential focus in genetic pleiotropy study is the selection of genetic
marker(s) with pleiotropic effect. Particularly, we are interested in testing the effect of
a genetic marker on the LV. Suppose that the fixed-effect covariates X in the second
part of the LVM has two components where X1 is the set of clinical covariates and
X2 is the genotype of the marker of interest. The two competing LV models are then
M0 :

yccitj = β0j +W
T
citβj + λjUcit + bcij + ecitj, j = 1, ..., J1,
y˜bcitj = β0j +W
T
citβj + λjUcit + bcij + ecitj, j = J1 + 1, ..., J,
Ucit = X
T
1cit
α1 + Z
T
citac +Q
T
citdci.
M1 :

yccitj = β0j +W
T
citβj + λjUcit + bcij + ecitj, j = 1, ..., J1,
y˜bcitj = β0j +W
T
citβj + λjUcit + bcij + ecitj, j = J1 + 1, ..., J,
Ucit = X
T
1cit
α1 +X
T
2cit
α2 + Z
T
citac +Q
T
citdci.
The two models can be linked up by the parameter g ∈ [0, 1] as:
Mg :

yccitj = β0j +W
T
citβj + λjUcit + bcij + ecitj, j = 1, ..., J1,
y˜bcitj = β0j +W
T
citβj + λjUcit + bcij + ecitj, j = J1 + 1, ..., J,
Ucit = X
T
1cit
α1 + gX
T
2cit
α2 + Z
T
citac +Q
T
citdci.
Let Lg be the complete-data likelihood for model Mg, then
U(Y,Ω,Θ, g(s)) =
∂ logLg
∂g
=
C∑
c=1
Nc∑
i=1
T∑
t=1
(
Ucit −XT1citα1 − g(s)XT2citα2 − ZTcitac −QTcitdci
)
XT2citα2.
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Again logBF can be obtained using (4.2) and (4.3) with U calculated as above.
5 Simulation study
We have identified three practically relevant issues related to the model’s performance
that we wanted to study via simulations: 1) the performance of our proposed method
in parameter estimation, 2) the effect of ignoring the family structure, and 3) the
performance of the proposed variable selection methods introduced in Section 4.
Table 1 provides the details of the simulation models in terms of phenotype
Y and covariates W and X specifications. Without loss of the generality, in all
simulations we assume that there are 500 families/clusters, each contributing 1, 2,
3, 4 or 5 siblings with probability, respectively, 0.3, 0.4, 0.2, 0.07 and 0.03. To
simulate the genotypes for the siblings, we set the minor allele frequency (MAF)
to be 0.1, and we assume that the parental genotypes for the 500 families follow
Hardy Weinberg equilibrium(HWE). The siblings’ genotypes are then obtained by
using Mendel’s first law of segregation. The parental genotypes however are not used
for the analysis because they are often not available in practical settings. Continuous
covariates are assumed to follow a N(0, 1) distribution with correlation coefficient
within the family (familial correlation) being 0.3 and individual-specific trajectories
for the covariate (serial correlation) follow an AR(1) model with autocorrelation being
0.3. We also assume that each phenotype is measured over time five times. Unless
specified otherwise, the default choice is pij ∼ Beta(1, 1) in the spike-and-slab prior
given in (3.3), assuming no prior information on the relationship between phenotype j
and the LV. In all the simulations, we run the MCMC algorithm for 25,000 iterations,
discarding the first 5,000 samples as burn-in.
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5.1 Parameter estimation for general traits.
To evaluate the performance of the proposed parameter estimation, we assume here
that five phenotypes are of interest among which y1, y2 and y3 are continuous, and y4
and y5 are binary (Tables 1 and 2). We use a total of 100 replications to study the
variation of estimates and also compare the performance of our PX2−HC algorithm
with those of the standard algorithms.
Figure 1 shows that, compared to AC-PX-HC, the standard PX algorithm with
the DA scheme of Albert and Chib (1993), the proposed PX2−HC algorithm dras-
tically reduces the autocorrelations between the chains’s realizations which implies
an increase in Monte Carlo efficiency. The improvement is also evident in Figure
2, when comparing the standard Gibbs (left column) with the proposed PX2−HC
scheme (right plots). In the Appendix, we provide the corresponding trace plots to
illustrate the improved mixing of the PX2−HC chain.
Table 2 shows the true values, mean estimates and root mean square errors
(RMSE) for all the parameters in the model. Results show that the estimates have
good accuracy with small bias and RMSE. However, parameter estimation for binary
responses is less accurate than for continuous phenotypes, which is not surprising
given the discrepancy between the information provided by the two types of data.
Figure 3 shows that around 95% of the HpdIs for the factor loadings λs cover
the true values. However, this remains to be validated theoretically for more general
setting as results seem to suggest a matching prior type of result.
5.2 Effect of Ignoring Family Structure
In this simulation, we only consider the three continuous phenotypes y1, y2 and y3
and generate data with familial and serial correlations as above in Section 5.1. We
compare parameter estimates obtained using the proposed method to model the fa-
milial correlation with the estimates obtained using the method of Roy and Lin (2000)
assuming samples are independent of each other.
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The simulation results in Table 3 show that failure to account for the familial
correlation present in the data will not only yield incorrect conclusion of the serial
correlations between phenotypes ΣD, but also cause over-estimation of the factor
loading λj, which quantifies the strength of the relationship between phenotype yj
and the latent variable U , and under-estimation of α1 and α2, which respectively,
represents the effect of the clinical covariate and genetic marker on U .
5.3 Model and Variable Selection
5.3.1 Selection of Relevant Phenotypes via Spike-and-Slab Priors
To assess the performance of phenotype selection using the spike-and-slab prior (3.3)
as described in Section 4.1, we consider here four continuous phenotypes yc with
factor loading λjs being set to (0.5, 0.05, 0.02, 0) and three binary phenotypes y
b with
λjs being (0.2, 0.01, 0). We chose these values so that the strength of the association
between a phenotype and the LV U ranges from strong (λj = 0.5) to no association
(λj = 0). We set pi ∼ Beta(0.25, 1) which favours a priori the null (λj = 0). After
the calculation of the posterior frequency of ωj = 1 for each phenotype in the 100
replicates, a threshold of φ = 50% is used on the posterior probability Pr(λj > 0|Y ).
Simulation results show that the type I error of this selection procedure is about
5% in that, for the phenotype not associated with the latent disease status (λj = 0),
around 5% of the replications have Pr(λj > 0|Y ) ≥ 0.5. For phenotypes moderately
or strongly associated the latent variable (λj = 0.05 or higher), we have 100% power
of making the correct decision. However, power is reduced for weakly associated
phenotypes as expected. Specifically for the case consider here, power is 71% for the
phenotype with λj = 0.02 and 16% for λj = 0.01.
5.3.2 Selection of Relevant Phenotypes via Bayes Factors
We have also examined the performance of phenotype selection via Bayes factors for
the comparison of model M1 (assuming λ > 0) and model M0 (assuming λ = 0) using
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the same simulation model as in the previous section. The logBF s for the λ’s are
calculated using the folded-t prior with df = 10 as described in Section 4.2.1.
Results in Table 4 show that when phenotype yj is truly associated with the latent
variable with λj ≥ 0.05, the average estimated log(BF ) > 5.9. This and combined
with the SD shown in the table suggest that, for such cases, the Bayes factor criterion
chooses the correct alternative model 100% of the times. When phenotype yj is truly
not associated with the LV (λj = 0), the Bayes factor criterion correctly favors the
null model with the average estimated log(BF ) < −2.4. However, the Bayes factor
criterion has little ability in identifying weakly associated phenotypes (λj ≤ 0.02),
which is inferior to the spike-and-slab approach in the previous section. We have also
explored the use of other folded-t priors with df ranging from 3, 10, 40 to 90. We find
that all the prior settings give us the same conclusion on the model selection.
5.3.3 Selection of Pleiotropic Genetic Marker or Other Covariates
For this purpose, we assume that there are five indirect fixed-effect covariatesX1, . . . , X5
in the second part of the LVM that models the effect of the genetic marker and other
covariates on the latent variable. We assume that X3 is the genotype of the marker
of interest and the remaining ones are standardized continuous variables. Coeffi-
cients (α1, α2, α3, α4, α5) quantify the effects of the five covariates which are set to
be (1.0,−0.5, 0.2, 0, 0). We also assume that there are two continuous standardized
direct fixed-effect covariates W1 and W2 in the first part of the LVM with effects
(β1 = 0.5 and β2 = 0.3) on all the phenotypes.
Table 5 shows the estimated log(BF ) for comparing the null model assuming
αj = 0 with the alternative of association. The prior distribution for α in (2.4) is
α ∼ N(0, I5). Results show that the proposed Bayes factor criterion has the ability to
detect the association between the genetic marker and the latent variable, therefore
pleiotropy, with the average estimated log(BF ) = 6.3 and SD = 2.39. The Bayes
factor variable selection criterion also has good result for the two associated covariates
X1 and X2 for which the average log(BF ) estimate is, respectively, 337.5 and 6.3, as
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well as for the two covariates X4 and X5 with zero effect, for which the estimated
log(BF ) is consistently less than −1.9 with SD = 0.42.
6 Application to a genetic study of type 1 diabetes
(T1D) complications.
Here we demonstrate the practical utility of the proposed LVM method by investigat-
ing the blood pressure data from a genome-wide association study (GAWS) of various
T1D complications (Paterson et al., 2010). The study sample consists of n = 1300
individuals with T1D from the Diabetes Control and Complications Trial (DCCT).
Various phenotypes thought be to related to T1D complication severity, including
glycosylated hemoglobin (HbA1c) and diastolic (DBP) and systolic blood pressure
(SBP), were collected from each subject over the course of the DCCT. Additional co-
variates such as sex and body mass index (BMI) were also collected, and individuals
were from two different cohorts and subjected to two treatment types (conventional
vs. intensive). Over 800K SNPs were genotyped by the Illumina 1M bead chip assay
for these individuals.
Because T1D is a complex disease with various complication measures (the ob-
served phenotypes), it is of great interest to quantify the conceptual latent complica-
tion status, as well as to understand the influencing factors (both genetic markers and
clinical covariates). In addition, it is valuable to determine if the various observed
phenotypes are truly associated with the latent variable. However, due to lack of
suitable statistical methodology, previous analyses have been limited to the standard
uni-phenotype approach, analyzing one phenotype at a time. For example, Ye et al.
(2010) recently performed GAWS, separately, for DBP and SBP, and they identified
rs7842868 on chromosome 8 as a SNP significantly associated with DBP.
Our goal here is to formally perform a multi-phenotype analysis, jointly analyzing
DBP and SBP using the proposed Bayesian LVM methodology. This approach allows
us not only to determine if rs7842868 is associated with the latent conceptual T1D
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complication variable, but also to test if DBP and SBP are truly related to the LV.
It is also of practical interest to study whether there are other phenotypes such as
hyperglycemia (HPG) influence the latent complication severity variable.
In our application, we investigate three phenotypes Y among which two are
continuous (DBP and SBP) and one is binary (HPG = 1 for hyperglycemia if and
= 0 for normal glycemia), all are longitudinal. Hyperglycemia at a given time point
is defined if the corresponding HbA1c is greater or equal to 8. Among the available
covariates, based on suggestions from clinicians, covariates W that have direct effects
on the phenotypes include BMI, and covariates X that have direct effects on the
LV include sex, cohort and treatment. Among the 10 longitudinal measurements
available, there are significant amount of missing data after the 7th measure (due to
staggered entry) while there are little missing data before the 5th measure. Therefore,
we only use the first five measurements. We treat the remaining missing data as
Missing at Random (MAR), and we replace the missing data with the means of all the
other measurements. In this dataset, there is only one person in each family therefore
there is no familial correlation, but the proposed methodology remains suitable by
assuming the cluster size being 1.
We first consider rs7842868, a SNP found by Ye et al. (2010) to be associated
with DBP. In this case X1 is the genotype of rs7842868. Results in Table 6 show
that DBP and SBP are clearly associated with the latent variable with estimated
logBF over 100, while HPG is not. We also applied the spike-and-slab prior method
for phenotype selection as discussed in Sections 4.1 and 5.3.1, the poster probability
Pr(λj > 0|Y ) is 1 for DBP and SBP and 0.235 for HPG. Thus all model selection
criteria consistently suggest that both DBP and SBP are significantly related to the
latent variable but not HPG. Results also show that SNP rs7842868 is significantly
associated with the latent variable with estimated logBF over 10 and the 95% HpdI
not covering 0. The sign of the effect suggest that the minor allele of the SNP is
protective in that it decreases the latent complication severity score. The combined
evidence from both parts of the LVM show that rs7842868 has pleiotropic effect on
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the two blood pressures. Sex and cohort are also found to be significantly associated
with the latent variable but not treatment.
We then investigate rs1358030, a SNP found by Paterson et al. (2010) to be
associated with HbA1c. In this case, X1 is the genotype of rs1358030. Based on
results in Table 6, there is no evidence that rs1358030 is significantly associated with
the latent variable. Our application here considers the binary hyperglycaemia (HPG)
as the third phenotype of interest instead of the continuous HbA1c variable. Besides
clinical consideration, this choice also allows us to evaluate the proposed method for
general traits as described in Section 3.2.2
To further evaluate the proposed method, we simulate genotypes for two NULL
SNPs that are not associated with the phenotypes of interest. One SNP has MAF
equal to 0.25, the MAF of rs7842868), and the other one has MAF equal to 0.35, the
MAF of rs1358030. As expected, no significant associations are detected.
7 Conclusion and Disucssion
We propose here a Bayesian latent variable approach to joint model multiple out-
comes, motivated by genetic association studies of pleiotropic effects. The method
can handle continuous and binary responses while accounting for serial and famil-
ial correlation structures in the data. The postulated latent variable represents the
underlying severity or complication level of a trait and characterizes the totality of
multiple observed phenotypes of interest. If additional phenotypes were to be mea-
sured, the latent variable could change its significance since it would encapsulate a
richer set of manifest variables. The central feature of the model is that it allows
us to consider the strength of dependence between the genotype and each of the
phenotypes in a unified manner. The Bayesian approach takes into account all the
uncertainty present in the model and incorporates prior information if available. The
computational challenges are met via the use of parametric expansion techniques.
An important issue for pleiotropy studies is the assessment of importance of each
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variable. We have adopted two Bayesian techniques that are shown to be effective in
variable selection. We found that both Bayes factor and spike-and-slab prior perform
well with the latter slightly more efficient in terms of detecting weak signals.
Our proof-of-principle application to a genetic study of type 1 diabetes compli-
cations demonstrates the utility of the method in a real data setting. So far, genetic
association studies of various T1D complication-related measures have been limited
to studying one phenotype at a time. The proposed method jointly analyzes two
continuous and one binary phenotypes of interest, and it provides evidence for the
association between the phenotypes and the latent severity of T1D complication, the
association between the latent variable and genetic markers of interest, and the effect
of other covariates on the phenotypes and the latent variable.
The computational load in the current implementation of the proposed method
makes it impractical to perform a genome-wide search for pleiotropic genetic variants.
The recent advances in parallel computing can partially alleviate this constraint.
Alternatively, a two-stage approach can be used in which a simple and less stringent
selection procedure is first used to select a moderate number of candidate variants
for further investigation using the proposed method. The uncertainty inherited from
the first-stage selection, however, must be accounted for in the models used in the
second stage.
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Table 2: Performance of the proposed parameter estimation method. First three phe-
notypes y1, y2 and y3 are continuous and the last two phenotypes y4 and y5 are binary.
Results are based on 100 replicates that were simulated as described in Section 5.1 and
Table 1.
First part of the latent variable model
Parameter True value Estimate RMSE
λj, the factor loading for phenotype yj and the latent variable U
λ1 1.0 1.000 0.007
λ2 1.0 1.000 0.007
λ3 1.0 1.000 0.007
λ4 1.0 1.000 0.022
λ5 1.0 0.998 0.025
βj for phenotype yj and covariate W
β1 1.0 1.000 0.011
β2 1.0 1.000 0.011
β3 1.0 1.000 0.011
β4 1.0 1.005 0.026
β5 1.0 0.996 0.031
Second part of the latent variable model
Parameter True value Estimate RMSE
α for the latent variable U and covariates (α2 for the genetic marker X2)
α1 1.0 0.999 0.011
α2 1.0 1.011 0.074
Correlation parameters
Parameter True value Estimate RMSE
τ 21 0.2 0.200 0.014
τ 22 0.2 0.201 0.012
τ 23 0.2 0.200 0.013
τ 24 0.2 0.202 0.033
τ 25 0.2 0.200 0.032
ΣA 0.5 0.519 0.046
ΣD 0.3 0.320 0.032
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Table 3: Effect of ignoring familial correlation present in the data. Results are the
averages over 100 simulation replications. The coefficient α2 evaluates the effect of
a genetic marker on the latent variable U (α1 for a clinical covariate on U), and λjs
evaluate the effect of U on the three phenotypes of interest. Details of the simulations
are in Section 5.2 and Table 1.
With Familial Corr. Without Familial Corr.
Parameters True Value Bias SD RMSE Bias SD RMSE
β
β1 1.0 -0.002 0.018 0.019 -0.003 0.028 0.027
β2 1.0 -0.001 0.020 0.019 -0.002 0.024 0.028
β3 1.0 -0.002 0.019 0.019 -0.003 0.027 0.028
α
α1 1.0 0.009 0.074 0.075 -0.233 0.099 0.235
α2 1.0 0.009 0.020 0.021 -0.227 0.028 0.244
λ
λ1 1.0 -0.009 0.014 0.015 0.308 0.029 0.310
λ2 1.0 -0.009 0.014 0.016 0.308 0.028 0.309
λ3 1.0 -0.009 0.015 0.015 0.308 0.029 0.309
τ 2
τ 21 0.2 -0.002 0.013 0.015 -0.001 0.015 0.015
τ 22 0.2 -0.001 0.012 0.014 -0.001 0.013 0.015
τ 23 0.2 -0.002 0.012 0.013 0.000 0.014 0.014
σ2
σ21 0.1 0.002 0.004 0.004 0.002 0.004 0.004
σ22 0.1 0.001 0.004 0.004 0.001 0.004 0.004
σ23 0.1 0.002 0.004 0.004 0.002 0.004 0.004
ΣA
(ΣA)11 1.0 -0.003 0.08 0.089 N/A N/A N/A
(ΣA)12 0.0 0.004 0.06 0.064 N/A N/A N/A
(ΣA)22 1.0 0.034 0.08 0.085 N/A N/A N/A
ΣD
(ΣD)11 0.1 0.049 0.020 0.053 0.69 0.06 0.696
(ΣD)12 0.0 0.000 0.011 0.011 -0.002 0.022 0.023
(ΣD)22 0.1 0.029 0.023 0.033 0.047 0.021 0.052
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Table 4: The estimated logBF for testing the factor loading λj. λj quantifies the
association between phenotype yj and the latent variable. Results are based on 50
simulated replicates. Details of the simulations are in Section 5.3.2 and Table 1.
Continuous Phenotypes Binary Phenotypes
y1 y2 y3 y4 y5 y6 y7
True λj 0.5 0.05 0.02 0 0.2 0.01 0
̂logBF 121.60 5.91 -1.76 -2.67 22.11 -2.43 -2.43
SD 6.47 2.22 1.05 0.47 8.19 0.32 0.13
Table 5: The estimated logBF for testing α = 0. α quantifies the association between
the covariates and the latent variable. Results are based on 50 simulated replicates.
Details of the simulations are in Section 5.3.3 and Table 1.
Covariates with effect on the latent variable
X1 X2 X3 (genotype) X4 X5
True α 1.0 -0.5 0.2 0 0
̂logBF 337.53 94.99 6.30 -1.94 -1.95
SD 33.25 11.19 2.39 0.46 0.42
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Table 6: Application results. SNP rs7842868 was previously identified to be associated
with diastolic blood pressure (DBP) and SNP rs1358030 was previously identified to
be associated with HbA1c. Phenotypes of interest are DBP and systolic blood pres-
sure (SBP), two continuous outcomes, and hyperglycemia (HPG, defined as HbA1c
greater or equal to 8), a binary outcome. All phenotypes are thought to be related
to type 1 diabetes complication severity. The coefficient λs assess the association
between the phenotypes and the latent T1D complication status, and αs evaluate
the association between the latent variable and the genetic marker and the other
covariates of interest. See Section 6 and Table 1 for more details.
Analysis of SNP rs7842868
Parameter Estimate 95% HpdI ̂logBF
SBP λ1 6.621 (6.153, 7.077) 114.85
DBP λ2 3.842 (3.566, 4.110) 112.98
HPG λ3 0.011 (2.189× 10−7, 2.975× 10−2) -1.05
rs7842868 α1 -0.269 (-0.372, -0.164) 10.06
sex α2 -0.721 (-0.866, -0.584) 62.27
cohort α3 0.443 ( 0.299, 0.585) 20.15
treatment α4 0.128 (-0.004, 0.263) 0.366
Analysis of SNP rs1358030
Parameter Estimate 95% HpdI ̂logBF
SBP λ1 6.868 (6.439, 7.302) 128.3
DBP λ2 3.706 (3.491, 3.933) 120.2
HPG λ3 0.010 (2.566× 10−7, 2.740× 10−7) -1.034
rs1358030 α1 - 0.039 (-0.049, 0.122) -1.104
sex α2 -0.758 (-0.880, -0.623) 64.86
cohort α3 0.393 (0.258, 0.532) 18.17
treatment α4 0.088 (-0.041, 0.220) -0.18
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Figure 1: Autocorrelation functions (ACF) for the AC-PX-HC (dashed line) scheme
and the proposed PX2-HC sampling scheme (solid line), averaged over 100 simulation
replicates. The autocorrelation is based on the posteriors of the factor loadings λ4 (left
panel) and λ5 (right panel) for the two binary phenotypes as simulated in Section 5.1
and described in Table 1.
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Figure 2: Autocorrelation functions (ACF) for the standard Gibbs (SG) sampling
scheme (left panel) and the proposed PX2-HC sampling scheme (right panel), averaged
over 100 simulation replicates. The autocorrelation is based on the posterior draws
for the three factor loadings λjs (j = 1, 2, 3) for the three continuous phenotypes, as
discussed in Section 5.1 and described in Table 1.
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